IDEAYA Biosciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Yujiro S. Hata, with a market cap of $2.7B.
Common questions about IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc. is scheduled to report earnings for Q1 2026 on May 5, 2026. Analysts estimate revenue of $5.9M.
IDEAYA Biosciences, Inc. has approximately 124 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.